Asence Pharma commences new plant at Ranoli, Vadodara
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Establishes distribution center in top hub for international shipping
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Subscribe To Our Newsletter & Stay Updated